跳至主要内容
临床试验/CTRI/2025/05/086449
CTRI/2025/05/086449尚未招募不适用

Treatment of Tinea Corporis (Padarthamarai) with Thipilliver Chooranam A Pilot Study

The Central Council for Research in Siddha1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年5月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
The primary outcome will be based on the resolution of skin lesions.

研究概览

简要总结

Tinea Corporis also known as ringworm, is a common fungal infection that affects the skin. The fungi causing Tinea Corporis persist on the skin for extended periods, making it challenging to fully eradicate with current treatment and leading to frequent relapses. Thipilliver Chooranam is a powder form of siddha medicine prescribed for ringworm fungal infection.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
All

入选标准

  • Patients who have ringworm infection.

排除标准

  • Immunocompromised patients
  • Children, Adolescent Pregnant/ Lactating women
  • Patients who have history of hypersensitivity/ Allergy 4.

结局指标

主要结局

The primary outcome will be based on the resolution of skin lesions.

时间窗: The outcome will be assessed after 4 weeks of intervention

次要结局

  • The secondary outcome will be based on the absence of fungi on the skin in the KOH wet mount test.(The outcome will be taken after 4 weeks of treatment.)

研究者

发起方
The Central Council for Research in Siddha
申办方类型
Research institution

研究点 (1)

Loading locations...

相似试验